NCT00005848View on ClinicalTrials.gov

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Prostate Cancer
Interventions
DRUG

chemotherapy

DRUG

tipifarnib

Trial Locations (2)

19111

Fox Chase Cancer Center, Philadelphia

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00005848 - R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter